Kevin T. Conroy - Dec 31, 2024 Form 5 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark Busch, attorney-in- fact
Stock symbol
EXAS
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
5
Date filed
4/29/2025, 04:10 PM
Previous filing
Nov 13, 2024
Next filing
Feb 21, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Gift $0 -74.6K -8.73% $0.00 780K May 14, 2024 Direct F1
holding EXAS Common Stock 28.1K Dec 31, 2024 Held in 401(k) Plan
holding EXAS Common Stock 73.3K Dec 31, 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 72.1K Dec 31, 2024 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 102K Dec 31, 2024 Held in Grantor Retained Annuity Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In addition to the shares of Common Stock reported on this Form 5, which total 1,054,875 shares, Mr. Conroy also held, in the aggregate, an additional 683,019 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.